查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434677

動物胜肽市場：依勝胜肽類型、產品來源分類 - 全球預測 2024-2030

Animal Antibacterial Peptide Market by Peptide Type (Anionic Peptides, Cationic Peptides, Linear Cationic Alpha-Helical Peptides), Product Origin (Cattle, Goat, Horse) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年動物胜肽市場規模為34.8億美元，預計2024年將達40.6億美元，2030年將達到104億美元，複合年成長率為16.92%。

全球獸用胜肽市場

主要市場統計
基準年[2023] 34.8億美元
預測年份 [2024] 40.6億美元
預測年份 [2030] 104億美元
複合年成長率（%） 16.92%
動物用抗菌胜肽市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估獸用胜肽市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對獸用胜肽市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-獸用胜肽市場規模及預測為何？

2-在獸用胜肽市場預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-獸用胜肽市場的技術趨勢和法律規範是什麼？

4-獸用胜肽市場主要供應商的市場佔有率是多少？

5-進入獸用胜肽市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 在動物飼料中增加使用低濃度抗生素作為生長促進劑
      • 大量使用抗生素來治療人類和動物的感染疾病
      • 感染疾病發生率不斷增加，對有效和安全藥物的需求不斷增加
    • 抑制因素
      • 臨床應用中的擔憂，例如毒性和免疫抗原性
    • 機會
      • 動物保健和新產品開發支出飆升
      • 提高對藥物療法和胜肽治療方法的認知
    • 任務
      • 抗生素抗藥性發生率增加
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 以勝胜肽類型分類的動物用胜肽市場

  • 陰離子胜肽
  • 陽離子勝胜肽
  • 鎖狀陽離子 A-螺旋胜肽

第7章獸用胜肽市場產品依產地分類

  • 牛
  • 山羊
  • 馬
  • 豬
  • 家禽
  • 羊

第8章：美洲動物胜肽市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太獸用胜肽市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲獸用胜肽市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第12章競爭產品組合

  • 主要公司簡介
    • Amicoat
    • Bayer AG
    • Boehringer Ingelheim GmbH
    • CPC Scientific Inc.
    • Dechra Pharmaceuticals PLC
    • Eli Lilly and Company
    • Endovac Animal Health LLC
    • Fort Dodge Animal Health
    • JPT Peptide Technologies
    • Merck & Co. Inc.
    • Mileutis LTD
    • Sanofi-Aventis Groupe SA
    • Vetoquinol SA
    • Virbac SA
    • Zoetis Inc.
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-4369010662D5

[195 Pages Report] The Animal Antibacterial Peptide Market size was estimated at USD 3.48 billion in 2023 and expected to reach USD 4.06 billion in 2024, at a CAGR 16.92% to reach USD 10.40 billion by 2030.

Global Animal Antibacterial Peptide Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.48 billion
Estimated Year [2024] USD 4.06 billion
Forecast Year [2030] USD 10.40 billion
CAGR (%) 16.92%
Animal Antibacterial Peptide Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Animal Antibacterial Peptide Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Antibacterial Peptide Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Animal Antibacterial Peptide Market, highlighting leading vendors and their innovative profiles. These include Amicoat, Bayer AG, Boehringer Ingelheim GmbH, CPC Scientific Inc., Dechra Pharmaceuticals PLC, Eli Lilly and Company, Endovac Animal Health LLC, Fort Dodge Animal Health, JPT Peptide Technologies, Merck & Co. Inc., Mileutis LTD, Sanofi-Aventis Groupe S.A., Vetoquinol SA, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Antibacterial Peptide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Peptide Type
    • Anionic Peptides
    • Cationic Peptides
    • Linear Cationic A-Helical Peptides
  • Product Origin
    • Cattle
    • Goat
    • Horse
    • Pig
    • Poultry
    • Sheep
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Animal Antibacterial Peptide Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Antibacterial Peptide Market?

3. What are the technology trends and regulatory frameworks in the Animal Antibacterial Peptide Market?

4. What is the market share of the leading vendors in the Animal Antibacterial Peptide Market?

5. Which modes and strategic moves are suitable for entering the Animal Antibacterial Peptide Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Animal Antibacterial Peptide Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of low levels of antibiotics as growth promoters in animal feeds
      • 5.1.1.2. Extensive use of antibiotics to treat human or animal infections
      • 5.1.1.3. Rising frequency of infectious diseases and the rising demand for effective and safe medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns in clinical applications such as the toxicity, and immunogenicity
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid rise in expenditure on animal healthcare and new product development efforts
      • 5.1.3.2. Growing awareness to medications and therapies incorporating antimicrobial peptides
    • 5.1.4. Challenges
      • 5.1.4.1. Proliferating incidences of antibiotic resistance
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Animal Antibacterial Peptide Market, by Peptide Type

  • 6.1. Introduction
  • 6.2. Anionic Peptides
  • 6.3. Cationic Peptides
  • 6.4. Linear Cationic A-Helical Peptides

7. Animal Antibacterial Peptide Market, by Product Origin

  • 7.1. Introduction
  • 7.2. Cattle
  • 7.3. Goat
  • 7.4. Horse
  • 7.5. Pig
  • 7.6. Poultry
  • 7.7. Sheep

8. Americas Animal Antibacterial Peptide Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Animal Antibacterial Peptide Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Animal Antibacterial Peptide Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Amicoat
    • 12.1.2. Bayer AG
    • 12.1.3. Boehringer Ingelheim GmbH
    • 12.1.4. CPC Scientific Inc.
    • 12.1.5. Dechra Pharmaceuticals PLC
    • 12.1.6. Eli Lilly and Company
    • 12.1.7. Endovac Animal Health LLC
    • 12.1.8. Fort Dodge Animal Health
    • 12.1.9. JPT Peptide Technologies
    • 12.1.10. Merck & Co. Inc.
    • 12.1.11. Mileutis LTD
    • 12.1.12. Sanofi-Aventis Groupe S.A.
    • 12.1.13. Vetoquinol SA
    • 12.1.14. Virbac S.A.
    • 12.1.15. Zoetis Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANIMAL ANTIBACTERIAL PEPTIDE MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANIMAL ANTIBACTERIAL PEPTIDE MARKET DYNAMICS
  • FIGURE 7. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2023 VS 2030 (%)
  • FIGURE 10. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIONIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY CATIONIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LINEAR CATIONIC A-HELICAL PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 10. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GOAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY HORSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PIG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 102. ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 103. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. ANIMAL ANTIBACTERIAL PEPTIDE MARKET LICENSE & PRICING